Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 1 Demographic, clinical and surgery-related characteristics of all patients
From: An evidence-based warfarin management protocol reduces surgical delay in hip fracture patients
Variable | Pre-protocol (n = 27) | Post-protocol (n = 40) | p value |
|---|---|---|---|
Age, median (IQR) | 81 (77–85) | 81.5 (76–88) | 0.67‡ |
Gender | |||
Male | 9 (33 %) | 18 (45 %) | 1.0* |
Female | 14 (67 %) | 26 (55 %) | |
Residential status | |||
Own home | 19 (70.3 %) | 30 (75 %) | 0.76† |
Residential home | 6 (22.2 %) | 6 (15 %) | |
Nursing home | 2 (7.4 %) | 3 (7.5 %) | |
In-patient | 0 (0 %) | 1 (2.5 %) | |
ASA grade | |||
I | 0 (0 %) | 0 (0 %) | 0.06† |
II | 12 (44.4 %) | 7 (17.5 %) | |
III | 9 (33 %) | 19 (47.5 %) | |
IV | 6 (22.2 %) | 14 (35 %) | |
Indication for warfarin therapy | |||
Atrial fibrillation | 16 (59.3 %) | 34 (85 %) | 0.001† |
Pulmonary embolism | 6 (22.2 %) | 3 (7.5 %) | |
Deep venous thrombosis | 3 (11.1 %) | 2 (5 %) | |
Others (thrombocytosis/valve replacement) | 2 (7.4 %) | 1 (2.5 %) | |
INR, mean (SD) | |||
At Admission | 3.4 (3.6) | 3.3 (2.6) | 0.08‡ |
Preoperative | 1.2 (0.2) | 1.3 (0.2) | 0.05‡ |
At Discharge | 2.3 (0.7) | 2.4 (0.8) | 0.73‡ |
Hb level (g/dl), mean (SD) | |||
Preoperative Hb | 12.3 (1.5) | 12.9 (1.9) | 0.12‡ |
Postoperative Hb | 10.3 (0.3) | 10.6 (0.3) | 0.57‡ |
Fall in Hb | 1.9 (1.1) | 2.3 (1.2) | 0.34‡ |
Type of implant | |||
Hemiarthroplasty | 13 (48.1 %) | 20 (50 %) | 0.85† |
DHS/CHS | 11 (40.7 %) | 14 (35 %) | |
Intra-medullary fixation | 3 (11.1 %) | 6 (15 %) | |
Surgeon grade | |||
Consultant | 11 (40.7 %) | 15 (37.5 %) | 0.80* |
Other | 16 (59.3 %) | 25 (62.5 %) | |
Anaesthetist grade | |||
Consultant | 26 (96.3 %) | 40 (100 %) | 0.40* |
Other | 1 (3.7 %) | 0 (0 %) | |
Anaesthesia technique | |||
General | 14 (51.8 %) | 23 (57.5 %) | 0.80* |
Regional | 13 (48.2 %) | 17 (42.5 %) | |